Table 2.
Group A | Group B | |
PIR at rest | 0.668 ± 0.178 | 0.248 ± 0.015# |
PIR at ATP stress | 0.725 ± 0.194 | 0.295 ± 0.107# |
EDV in the acute phase (ml) | 112 ± 33 | 146 ± 38 |
EDV at follow-up (ml) | 114 ± 30 | 192 ± 39* |
EF in the acute phase (%) | 50 ± 7 | 45 ± 9 |
EF at follow-up (%) | 52 ± 7 | 39 ± 9* |
LVWMI in the acute phase | 2.1 ± 0.7 | 2.4 ± 0.3 |
LVWMI at follow-up | 1.7 ± 0.4 | 2.4 ± 0.3* |
Peak creatine kinase (U/L) | 2734 ± 868 | 6198 ± 2265* |
CFR | 2.60 ± 0.8 | 1.31 ± 0.29* |
#p < 0.05, *p < 0.01
PIR, peak intensity ratio; EDV, end-diastolic volume; EF, ejection fraction; CFR, coronary blood flow reserve; LVWMI, left ventricular wall motion index